rs1555781739
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_003072.5(SMARCA4):c.3216-5T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003072.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.3216-5T>A | splice_region_variant, intron_variant | NM_001387283.1 | ENSP00000495368.1 | |||||
SMARCA4 | ENST00000344626.10 | c.3216-5T>A | splice_region_variant, intron_variant | 1 | NM_003072.5 | ENSP00000343896.4 | ||||
SMARCA4 | ENST00000643549.1 | c.3216-5T>A | splice_region_variant, intron_variant | ENSP00000493975.1 | ||||||
SMARCA4 | ENST00000541122.6 | c.3216-5T>A | splice_region_variant, intron_variant | 5 | ENSP00000445036.2 | |||||
SMARCA4 | ENST00000643296.1 | c.3216-5T>A | splice_region_variant, intron_variant | ENSP00000496635.1 | ||||||
SMARCA4 | ENST00000644737.1 | c.3216-5T>A | splice_region_variant, intron_variant | ENSP00000495548.1 | ||||||
SMARCA4 | ENST00000589677.5 | c.3216-5T>A | splice_region_variant, intron_variant | 5 | ENSP00000464778.1 | |||||
SMARCA4 | ENST00000643995.1 | c.2628-5T>A | splice_region_variant, intron_variant | ENSP00000496004.1 | ||||||
SMARCA4 | ENST00000644963.1 | c.1860-5T>A | splice_region_variant, intron_variant | ENSP00000495599.1 | ||||||
SMARCA4 | ENST00000644065.1 | c.1941-5T>A | splice_region_variant, intron_variant | ENSP00000493615.1 | ||||||
SMARCA4 | ENST00000642350.1 | c.1701-5T>A | splice_region_variant, intron_variant | ENSP00000495355.1 | ||||||
SMARCA4 | ENST00000643857.1 | c.1569-5T>A | splice_region_variant, intron_variant | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152164Hom.: 0 Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152164Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74346
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 16 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 14, 2021 | The c.3216-5T>A intronic variant results from a T to A substitution 5 nucleotides upstream from coding exon 23 in the SMARCA4 gene. This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive and direct evidence is insufficient at this time (Ambry internal data). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Rhabdoid tumor predisposition syndrome 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at